BMRN vs MBUU · P/E 40, rev $1.76B vs rev $914.6M
Biomarin Pharmaceutical Inc (BMRN) versus Malibu Boats Inc (MBUU) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Malibu Boats Inc (MBUU) is a recreational vehicles company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported MBUU revenue for 2026-06-30 was $914.6M. Net income was $1.7M. Revenue was up 13.3% from 2025-06-30 to 2026-06-30. MBUU currently screens at market cap $674.9M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. MBUU currently screens at market cap $674.9M.
Not investment advice. Open the BMRN and MBUU stock pages for the full models.
Not investment advice.